武汉云克隆科技股份有限公司

抗血管内皮生长因子165(VEGF165)单克隆抗体

Anti-Vascular Endothelial Growth Factor 165 (VEGF165) Monoclonal Antibody

  • 抗血管内皮生长因子165(VEGF165)单克隆抗体产品包装(模拟)
  • 抗血管内皮生长因子165(VEGF165)单克隆抗体产品包装(模拟)
  • 抗血管内皮生长因子165(VEGF165)单克隆抗体Human Hela cell line was fixed with 2% paraformaldehyde (10 min) , permeabilised with 0.1% BSA-Triton X-100,then stained with 10µg/ml mouse Anti-human VEGF165 Monoclonal Antibody (Catalog FAB696Hu08, red histogram) or Isotype control antibody (Catalog IS067-Mu03, green histogram), followed by 1µg/ml FITC-conjugated Anti-mouse IgG Secondary Antibody (Catalog SAA544Mu18).
  • Certificate通过ISO 9001、ISO 13485质量体系认证

用法

Western blotting: 0.2-2μg/mL;
Immunohistochemistry: 5-20μg/mL;
Immunocytochemistry: 5-20μg/mL;
Flow cytometry:10μg/ml;
Optimal working dilutions must be determined by end user.

储存

经常使用则4°C保存。-20°C保存不超过一年。避免反复冻融。

赠品

相关产品

编号适用物种：Homo sapiens (Human，人)应用(仅供研究使用，不用于临床诊断！)
APB696Hu61血管内皮生长因子165(VEGF165)活性蛋白Cell culture; Activity Assays.
APB696Hu01血管内皮生长因子165(VEGF165)活性蛋白Cell culture; Activity Assays.
RPB696Hu01血管内皮生长因子165(VEGF165)重组蛋白Positive Control; Immunogen; SDS-PAGE; WB.
EPB696Hu61血管内皮生长因子165(VEGF165)真核蛋白Positive Control; Immunogen; SDS-PAGE; WB.
PAB696Hu01血管内皮生长因子165(VEGF165)多克隆抗体WB; IHC; ICC; IP.
MAB696Hu21血管内皮生长因子165(VEGF165)单克隆抗体WB; IHC
MAB696Hu22血管内皮生长因子165(VEGF165)单克隆抗体WB; IHC; ICC; IP.
MAB696Hu25血管内皮生长因子165(VEGF165)单克隆抗体WB; IHC; ICC; IP.
MAB696Hu24血管内皮生长因子165(VEGF165)单克隆抗体WB; IHC; ICC; IP.
MAB696Hu23血管内皮生长因子165(VEGF165)单克隆抗体WB; IHC; ICC; IP.
MAB696Hu26血管内皮生长因子165(VEGF165)单克隆抗体WB; IHC; ICC; IP.
MAB696Hu27血管内皮生长因子165(VEGF165)单克隆抗体WB; IHC; ICC; IP.
MAB696Hu29血管内皮生长因子165(VEGF165)单克隆抗体WB; IHC; ICC; IP.
FAB696Hu08抗血管内皮生长因子165(VEGF165)单克隆抗体Flow cytometry.
FAB696Hu06抗血管内皮生长因子165(VEGF165)单克隆抗体Flow cytometry.
FAB696Hu02抗血管内皮生长因子165(VEGF165)单克隆抗体Flow cytometry.
FAB696Hu04抗血管内皮生长因子165(VEGF165)单克隆抗体Flow cytometry.
SEB696Hu血管内皮生长因子165(VEGF165)检测试剂盒(酶联免疫吸附试验法)Enzyme-linked immunosorbent assay for Antigen Detection.
LMB696Hu血管内皮生长因子165(VEGF165)等多因子检测试剂盒(流式荧光发光法)FLIA Kit for Antigen Detection.

参考文献

杂志参考文献
OncotargetProhibitin, relocated to the front ends, can control the migration directionality of colorectal cancer cells.[pubmed:29100316]
Tissue Eng Regen MedOsteogenic and Angiogenic Potency of VEGF165-Transfected Canine Bone Marrow Mesenchymal Cells Combined with Coral Hydroxyapatite in Vitro[34302695]